Full-Time
Director of Client Services
Updated on 9/3/2026
Inizio Engage
501-1,000 employees
Provides integrated data insights for pharma
No salary listed
Philadelphia, PA, USA
Hybrid
Hybrid remote/in-office work is required.
 Sales & Account Management (1) |
|---|
Get referred to Inizio Engage
See people who can refer or advise you
- At least 8 years of experience in client services or account leadership within a healthcare, pharmaceutical, or life sciences agency.
- Experience growing strategic client relationships.
- Experience leading complex, high-value accounts and overseeing multiple client programmes.
- Confidence working with senior client partners, including executive leadership teams.
- Experience developing account growth plans and identifying new commercial opportunities.
- Commercial awareness, including forecasting and portfolio management.
- Ability to lead diverse teams and influence partners across an organisation.
- Experience developing others through a collaborative leadership style.
- Manage a portfolio of healthcare and pharmaceutical client accounts.
- Build trusted relationships with senior partners, including C-suite leaders.
- Identify opportunities to expand existing partnerships and introduce new services.
- Work with business development colleagues to win new work and grow new client relationships.
- Develop account plans that support long-term client growth.
- Lead strategic client conversations, business reviews, and planning meetings.
- Turn client briefs into clear, relevant plans for delivery teams.
- Partner with creative, strategy, production, and specialist teams to develop appropriate solutions.
- Lead and support pitches for new opportunities.
- Mentor Account Directors and wider account teams, helping them develop and succeed.
- Serve as the senior escalation point for client issues and find practical solutions when challenges arise.
- Manage account forecasting, revenue, and profitability to ensure projects are commercially successful.
- Ensure projects are resourced and delivered to a high standard by working with operations.
Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Dublin Township, Pennsylvania
Founded
N/A
Get referred to Inizio Engage
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 2026 Connected Insights expands APAC medical information and adds speech analytics, virtual agents.
- April 2026 Hub Services launch strengthens patient access programs at Asembia, a major industry venue.
- September 2026 events calendar shows active marketing at PIPA, Fierce Pharma Week, and expopharm.
What critics are saying
- Inizio's AI tools commoditize skilled service labor, pressuring pricing when pharma buyers benchmark automation in 2027.
- Revelio estimated 332 active job postings in 2026, down 102.4 percent from 2025.
- If major clients internalize patient support, Engage loses scale fast.
What makes Inizio Engage unique
- Inizio Engage runs 6,000 experts across 20+ countries, giving local execution at global scale.
- Its April 2026 Hub Services unify access, reimbursement, pharmacy, and adherence in one platform.
- Connected Insights turns one million scientific interactions into medical-information intelligence and AI-enabled workflows.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Private Medical Insurance
Life Insurance
Pension Scheme
Hybrid Work Options
Paid Vacation
401(k) Retirement Plan
Company News
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50
We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.
Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.
After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.
Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.